NCT02922296View on ClinicalTrials.gov

Glucose Metabolism in Sickle Cell Disease

Active, not recruitingOBSERVATIONAL

Enrollment

75

Participants

Timeline

Start Date

May 1, 2015

Primary Completion Date

August 1, 2026

Study Completion Date

August 1, 2026

Conditions

Sickle Cell DiseaseDiabetes Mellitus

Trial Locations (1)

60612

University of Illinois at Chicago, Chicago

All Listed Sponsors

lead

University of Illinois at Chicago

OTHER